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background:  Non-pulmonary vein (non-PV) triggers and left atrial (LA) scars perpetuate atrial fibrillation (AF) and limit the success rate 
of catheter ablation. As these risk factors manifest in some AF patients and not in all, understanding their genetic basis will offer insight 
into the inter-individual differences in the clinical presentation and therapeutic approaches of this complex arrhythmia. We examined the 
association of selected single nucleotide polymorphisms (SNPs) with scar and non-PV triggers.
Methods:  Four hundred AF patients (67% male, 62±12 year, LA size 45.3±7 mm, 64% non-paroxysmal) undergoing catheter ablation were 
prospectively enrolled at our center. DNA extraction and genotyping for 16 AF-related SNPS from blood samples were performed using 
Qiagen QiaAMP kit and TaqMan assay respectively. Three hundred seventy two DNA samples were available for genotyping. Multivariate 
logistic regression analysis (adjusted covariates: age, gender, LA size, hypertension and diabetes) was used for assessing predictive role 
of individual SNP; and logistic kernel-machine approach was applied to test the cumulative effect of multiple SNPs as a group with non-PV 
triggers and LA scar.
results:  SNPs, rs6599230, rs6843082, were inversely associated (OR 0.68, p= 0.04; and 0.62, p=0.01 respectively) whereas rs1448817 
(OR 1.74, p= 0.04), and rs7193343 (OR 1.66, p= 0.02) predicted higher risk of non-PV triggers. Genotypes for rs6599230 and rs6843082 
conferred 51% reduction in the odds for non-PV triggers (combined OR 0.49, p=0.019), while rs1448817 and rs7193343 demonstrated 
a combined OR of 1.93, p=0.025. For LA scar, inverse association was observed with rs1448817 (OR 0.29, p=0.006), rs17042171 (OR 
0.27, p=0.032), rs3807989 (OR 0.54, p=0.017), and rs6843082 (OR 0.56, p=0.009). Two SNPs were associated with increased scar risk; 
rs17375901 (OR 3.68, p=0.03), and rs7193343 (OR 1.74, p=0.037).
Conclusion:  We identified novel genetic markers that influence the risk for non-PV triggers and LA scar in atrial fibrillation patients. Our 
results suggest that in patients carrying those risk variants, operators may need to adopt individualized ablation strategies to maximize 
procedural success.
